CK-MB assay

For the quantitative in vitro determination of CK-MB in serum or plasma. This product is suitable for automated, semi-automated and manual use.

SKU: CK3813 Categories: , , , , , , , Method: Immunoinhibition Format: Lyophilised Size: R1a 2x70ml, R1b 4 x 20ml, R2 4 x 6ml Assay Range: Assay range of 8.30 to 1182 U/I Working Stability: To expiry at +2 to +8℃ Available Applications: RX daytona, RX daytona+, RX imola, RX monaco Tags: , , , , , ,

$671.04

In stock

$671.04

Description

Description

Intended Use

For the quantitative in vitro determination of CK-MB in serum or plasma. This product is suitable for automated, semi-automated and manual use.

Clinical Significance

Creatine Kinase (CK) is internationally accepted as a sensitive and specific indicator of acute myocardial infarction (AMI). There are 3 iso-enzymes of CK, CK-MM, CK-MB and CK-BB. CK-BB is produced by the brain in very small insignificant amounts. CK-MM is produced by the skeletal and heart tissue and CK-MB is produced by the heart muscle. In the vast majority of cases the CK activity rises within 6 hours of an acute infarction. After about 20 hours maximum values are observed. The CK activity generally returns to normal between the fourth and fifth day post- infarction.

Available Applications

  • RX daytona
  • RX daytona+
  • RX imola
  • RX monaco